BRENDA BENNETT: Open Payments
NPI 1437267119 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 49 payments from 7 companies in 2025. Trend: 2023 $1,124 · 2024 $1,107 · 2025 $1,106
Food & beverage: $1,037Education: $69
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $434 |
| ViiV Healthcare Company | 7 | $179 |
| Merck Sharp & Dohme LLC | 7 | $157 |
| Astellas Pharma US Inc | 5 | $154 |
| Melinta Therapeutics, LLC | 5 | $98 |
| ABBVIE INC. | 3 | $62 |
| Insmed, Inc. | 1 | $23 |
Products named: ZERBAXA, Rezzayo, Cresemba, CABENUVA, APRETUDE, Biktarvy, PREVYMIS, DOVATO.
Industry payments across MS — which companies pay providers there.
